Literature DB >> 3713797

Study on the evaluation of the use of thiabendazole in the treatment and control of bovine dermatophytosis.

M A Gabal.   

Abstract

A study on the use of thiabendazole in the treatment of bovine dermatophytosis caused by Trichophyton verrucosum was conducted. Fifteen infected animals were included in the study. Ten animals were treated with a thiabendazole-DMSO-salicylic acid mixture and 5 animals were left untreated as controls. The thiabendazole mixture was used topically on the skin lesions. Lesions resolved after 12 applications and 80% of the treated animals proved negative on mycological examination. All lesions healed completely after 16 applications. Thiabendazole proved to be fungicidal on specimens of skin scrapings infected with the arthroconidia and mycelial elements of the dermatophyte. The killing effect was achieved using dilutions of 1:10 000 and 1:20 000 at 4 and 7 days, respectively.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3713797     DOI: 10.1007/bf00443519

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  4 in total

1.  ANTIMYCOTIC PROPERTIES OF THIABENDAZOLE.

Authors:  H J ROBINSON; H F PHARES; O E GRAESSLE
Journal:  J Invest Dermatol       Date:  1964-06       Impact factor: 8.551

Review 2.  Chemotherapy for the systemic mycoses: the prelude to ketoconazole.

Authors:  J P Utz
Journal:  Rev Infect Dis       Date:  1980 Jul-Aug

3.  In-vitro studies of a new oral azole antimycotic, BAY N 7133.

Authors:  H Yamaguchi; T Hiratani; M Plempel
Journal:  J Antimicrob Chemother       Date:  1983-02       Impact factor: 5.790

4.  Bone and joint coccidioidomycosis treated with miconazole.

Authors:  S C Deresinski; D A Stevens
Journal:  Am Rev Respir Dis       Date:  1979-11
  4 in total
  1 in total

Review 1.  Common fungal infections of the feet in patients with diabetes mellitus.

Authors:  James S Tan; Warren S Joseph
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.